Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Michael Lao, MD

Advertisement

Articles by Michael Lao, MD

Robotic simple suprapubic prostatectomy for large prostatic adenoma

ByMichael Lao, MD,Jacob A. Baber, MD,Joseph R. Wagner, MD
April 24th 2018

This video from Michael Lao, MD, Jacob A. Baber, MD, and Joseph R. Wagner, MD, depicts a minimally invasive robotic approach for a large symptomatic prostatic adenoma with bladder calculi.

Advertisement

Latest Updated Articles

  • Robotic simple suprapubic prostatectomy for large prostatic adenoma
    Robotic simple suprapubic prostatectomy for large prostatic adenoma

    April 24th 2018



Advertisement
Advertisement

Trending on Urology Times

1

UGN-501 enters phase 1 testing for recurrent non–muscle invasive bladder cancer

2

Infertility care: Examining geographic gaps in access

3

ESMO 2026 On Location - Why pCR is not the whole story in cisplatin-ineligible MIBC

4

Alicia Morgans, MD, discusses cognitive outcomes with darolutamide vs enzalutamide

5

UGN-101 shows durable responses in low-grade upper tract urothelial carcinoma

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us